Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sadao Nakane is active.

Publication


Featured researches published by Sadao Nakane.


Mutation Research | 1995

Efficient induction of chromosome-type aberrations by topoisomerase II inhibitors closely associated with stabilization of the cleavable complex in cultured fibroblastic cells

Hiroshi Suzuki; Tomotake Ikeda; Takehiro Yamagishi; Shiro Nakaike; Sadao Nakane; Motoyasu Ohsawa

Eukaryotic topoisomerase II (Topo-II) inhibitors such as etoposide, adriamycin and mitoxantrone, which commonly stabilize the cleavable complex of the enzyme and DNA, have been found to efficiently induce chromosome-type aberrations (mainly breaks and exchanges) in cultured Chinese hamster lung fibroblastic cells (CHL cells). To clarify whether the induction of chromosome-type aberrations is mediated by stabilization of the cleavable complex, the present study investigated (1) the correlation between the induction of chromosome-type aberrations and the amount of cleavable complex formed; and (2) the ATP dependence of the Topo-II inhibitor-induced chromosome-type aberrations due to the ATP requirement of cleavable complex formation by Topo-II. First, in cells treated with the Topo-II inhibitors, (etoposide, adriamycin) and aclarubicin, an antagonist of the inhibitor of cleavable complex formation, the frequency of chromosome-type aberrations decreased dose-dependently with aclarubicin, in contrast to an increase of chromatid-type aberrations. The formation of the cleavable complex was further established by a proteinase K/SDS precipitation assay for cleaved double-strand DNA in a cell-free system and in CHL cells. Results from both experiments showed that aclarubicin caused a dose-dependent suppression of the accumulation of the cleavable complex induced by etoposide, which corresponded particularly well to the reduction of chromosome-type aberrations in etoposide-treated cells. In ATP-depleted cells simultaneously treated with etoposide and dinitrophenol (DNP), chromosome-type aberrations were reduced as compared with DNP-untreated cells, in contrast to an increase of chromatid exchanges in the cells. This means that etoposide-induced chromosome-type aberrations in ATP-depleted cells may be attributable to incompleteness of Topo-II activities to form DNA double-strand breaks. The present findings indicate that the stabilization of the cleavable complex on Topo-II is closely associated with the induction of chromosome-type aberrations.


Folia Pharmacologica Japonica | 1974

Effect of several drugs on the development of stress ulcer and seepage of a pigment from the stomach of rats

Sadao Nakane; Takeshi Sakai

本研究において,自律神経薬ほか諸種薬物の潰瘍形成と胃液分泌およびPSB漏出量におよぼす影響を検討し,以下の結果を得た.1)本実験で,phenoxybenzamineを除き,ストレス潰瘍抑制作用を示した薬物は,潰瘍抑制量で胃液分泌減少とpH上昇作用を示した.このことは,ストレス潰瘍抑制には胃液分泌の抑制が重要な要因であることを示唆するものと考えられる.2)atropineは,潰瘍抑制量において,ストレスによるPSB量減少に対し,少くとも増強作用を示さなかった.また,propranolol,DCIおよびchlorpromazineは,ストレスによるPSB量減少に対し,むしろ阻止的であった.これより,ストレスによる胃粘膜血流の阻止ないし抑制が抗潰瘍作用の一因となると考えられる.


Chemical & Pharmaceutical Bulletin | 1979

Anti-ulcer effect of isoprenyl flavonoids. II. Synthesis and anti-ulcer activity of new chalcones related to sophoradin.

Kazuaki Kyogoku; Katsuo Hatayama; Sadakazu Yokomori; Ryuichi Saziki; Sadao Nakane; Michitada Sasajima; Jiro Sawada; Masahiro Ohzeki; Ichiro Tanaka


Journal of Toxicological Sciences | 1995

Predictability of clinical adverse reactions of drugs by general pharmacology studies

Toshiji Igarashi; Sadao Nakane; Toshikazu Kitagawa


Journal of Toxicological Sciences | 1981

STUDIES ON TOXICITY OF HYDROCORTISONE 17-BUTYRATE 21- PROPIONATE : 1. Acute Toxicity of Hydrocortisone 17-Butyrate 21-Propionate and Its Analogues in Mice, Rats and Dogs

Yasuo Tarumoto; Satoshi Abe; Yoshifumi Tsutsui; Sadao Nakane; Michitada Sasajima; Masahiro Ohzeki


Folia Pharmacologica Japonica | 1978

[Studies on the anti-ulcer effects of isoprenyl flavonoids (1). The anti-ulcer effects of isoprenyl chalcone extracted from Sophora subprostrata (author's transl)].

Michitada Sasajima; Sadao Nakane; Ryuichi Saziki; Hideo Saotome; Katsuo Hatayama; Kazuaki Kyogoku; Ichiro Tanaka


Biological & Pharmaceutical Bulletin | 1994

Differential Induction of Chromosomal Aberrations by Topoisomerase Inhibitors in Cultured Chinese Hamster Cells

Hiroshi Suzuki; Sadao Nakane


Japanese Journal of Pharmacology | 1980

THE ACTION OF CHLORPHENESIN CARBAMATE ON THE FROG SPINAL CORD

Hironaka Aihara; Michio Kurachi; Sadao Nakane; Michitada Sasajima; Masahiro Ohzeki


Japanese Journal of Pharmacology | 1984

Effect of 2'-carboxymethoxy-4,4'-bis(3-methyl-2-butenyloxy) chalcone (sofalcone) on chronic gastric ulcers in rats.

Masaaki Kimura; Ryuichi Saziki; Iwao Arai; Yasuo Tarumoto; Sadao Nakane


Japanese Journal of Pharmacology | 1974

EFFECTS OF BIOGENIC MONOAMINES AND PRECURSORS ON STRESS ULCERS AND SECRETION IN STOMACH

Sadao Nakane; Takeshi Sakai

Collaboration


Dive into the Sadao Nakane's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Masahiro Ohzeki

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Yasuo Tarumoto

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Ryuichi Saziki

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Takashi Ohshima

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Takeshi Sakai

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Hisaharu Yamada

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Iwao Arai

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Masaaki Kimura

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge